PARP1 and melanoma: Representative photomicrographs showing a clear rescue effect of the drug combination in the P53 knock-out subline are depicted in Figure 5C. A pronounced antagonistic activity of PARP inhibitors in combination with YK-4-279 was also observed in several melanoma models preferentially in p53 non-responsive cases (Supplementary Figure S9).